which may lead to the development of new psoriatic lesions (Koebner phenomenon). Patients should also be informed about the potential for developing chronic plaque-type psoriasis. Education about ...

A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis,” published in the November 2024 issue of Dermatology by Ferris et al.